Search Results for "medroxyprogesterone"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for medroxyprogesterone. Results 11 to 16 of 16 total matches.
See also: Premphase, Prempro

Treatment of Menopausal Vasomotor Symptoms

   
The Medical Letter on Drugs and Therapeutics • Dec 06, 2004  (Issue 1197)
-progestin combinations Prempro (Wyeth-Ayerst) 3 0.3 mg CEE/1.5 mg medroxyprogesterone, 0.45/1.5 mg ...
Estrogen is the most effective treatment for menopausal vasomotor symptoms (hot flashes), but the Women's Health Initiative study found that women who took estrogen plus a progestin for more than 5 years were at increased risk for myocardial infarction, stroke, pulmonary emboli, deep vein thrombosis, breast cancer, and possibly dementia. Are there effective alternatives?
Med Lett Drugs Ther. 2004 Dec 6;46(1197):98-9 |  Show IntroductionHide Introduction

Choice of Contraceptives

   
The Medical Letter on Drugs and Therapeutics • May 15, 2023  (Issue 1676)
bleeding in first 3-6 months; headache; nausea; acne; ovarian cysts Injectable (medroxyprogesterone ...
Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also effective in preventing pregnancy. When used alone, barrier and behavioral methods generally have higher failure rates than other methods (see Table 1). Selection of a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80   doi:10.58347/tml.2023.1676a |  Show IntroductionHide Introduction

Estetrol/Drospirenone (Nextstellis) - A New Combination Oral Contraceptive

   
The Medical Letter on Drugs and Therapeutics • Jun 28, 2021  (Issue 1627)
and progestin-only oral contraceptives, transdermal patches, vaginal rings, and injectable medroxyprogesterone ...
The FDA has approved a combination oral contraceptive containing the estrogen estetrol and the progestin drospirenone (Nextstellis – Mithra/Mayne). Estetrol is the first new estrogen to become available in the US in 50 years. Drospirenone is available alone (Slynd) and in combinations with the estrogen ethinyl estradiol for prevention of pregnancy.
Med Lett Drugs Ther. 2021 Jun 28;63(1627):101-2 |  Show IntroductionHide Introduction

New Drugs for Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Jan 05, 1996  (Issue 965)
. N.A. Estrogens, conjugated − Premarin (Wyeth-Ayerst) 0.625 mg 11.05 Medroxyprogesterone − average ...
Two new drugs alendronate (Fosamax - Merck) and salmon calcitonin nasalspray (Miacalcin - Sandoz) are now available in the USA for treatment of postmenopausalosteoporosis. A third drug for treatment of osteoporosis, a slow-release fluoridepreparation (Slow Fluoride -Mission Pharmacal), has been recommended for approvalby an advisory committee of the US Food and Drug Administration (FDA). Various formulationsof fluoride have been available in Europe for this indication for many years.
Med Lett Drugs Ther. 1996 Jan 5;38(965):1-3 |  Show IntroductionHide Introduction

Drugs of Choice for Cancer Chemotherapy

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 1995  (Issue 945)
-Provera − medroxyprogesterone acetate Doxil − liposomal doxorubicin *DTIC-Dome − dacarbazine Ellence ...
Med Lett Drugs Ther. 1995 Mar 31;37(945):25-32 |  Show IntroductionHide Introduction

Drugs of Choice for Cancer

   
Treatment Guidelines from The Medical Letter • Mar 01, 2003  (Issue 7)
– chlorozotocin Depo-Provera – medroxyprogesterone acetate Doxil – liposomal doxorubicin * DTIC-Dome ...
The tables in this article list drugs used for treatment of cancer in the USA and Canada and their major adverse effects. The choice of drugs in Table I is based on the opinions of Medical Letter consultants. Some drugs are listed for indications for which they have not been approved by the US Food and Drug Administration. In some cases, such as elderly patients or those with many co-morbid illnesses, the regimen of choice might not be suitable. For many of the cancers listed, surgery and/or radiation therapy may be the treatment of choice or may also be part of the management. Anticancer...
Treat Guidel Med Lett. 2003 Mar;1(7):41-52 |  Show IntroductionHide Introduction